Related Experiment Video
Updated: Apr 10, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Transcriptional regulatory network analysis uncovers modular gene control and potential key regulators in diabetic
Fernanda Fredericksen1,2,3, Víctor Aliaga-Tobar4,5, Sebastián Aedo-Cares6,7,8
1Millennium Institute Center for Genome Regulation (MI-CGR), Santiago, Chile.
Introduction:
Diabetic cardiomyopathy (DCM) arises from the interplay of metabolic overload, inflammation, and structural remodeling that ultimately impair cardiac function. However, the transcriptional mechanisms coordinating these pathogenic processes remain incompletely defined. This study aimed to reconstruct and functionally characterize the transcriptional regulatory architecture associated with DCM.
Methods:
We combined differential expression data from human hiPSC-derived cardiomyocytes exposed to diabetic conditions with literature-curated transcription factor-target interactions to reconstruct a comprehensive transcriptional regulatory subnetwork for DCM. Network topology and functional enrichment analyses were performed to identify regulatory modules and hierarchical organization. Selected network-derived predictions were experimentally evaluated in a type 2 diabetes mouse model.
Results:
Transcriptional reprogramming was organized into six functional modules encompassing metabolic, inflammatory, hypoxic, fibrotic, and hormonal pathways. Established DCM-associated transcription factors, including FOS, JUN, STAT3, and MYC, ranked among the highest-centrality hubs. Notably, ESR1, a key regulator of estrogen signaling, emerged as a previously unrecognized high-centrality node within the DCM network. In contrast, TRPS1, HBP1, and NFIA showed lower centrality and operated as locally acting regulators, consistent with a multilayered regulatory architecture. Experimental validation in diabetic mice demonstrated significant downregulation of ESR1 and STAT6, together with upregulation of TRPS1 and HBP1, supporting cross-species concordance of selected regulatory signatures.
Discussion:
These findings define the modular organization of a curated transcriptional regulatory subnetwork underlying DCM and highlight candidate regulators that warrant future functional perturbation studies and biomarker-oriented validation. This integrative network-based framework provides mechanistic insight into transcriptional coordination in diabetic cardiac disease.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
09:29Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Master Transcription Regulators
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy